Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS

SIMPLE SUMMARY: RAS oncoproteins are considered undruggable cancer targets. Nearly 15% of cases of bladder cancer have a mutation of HRAS. The active HRAS contributes to the tumor progression and the risk of recurrence. Using our novel gene expression screening platform, pterostilbene was identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Ting, Huang, Zi-Yi, Tang, Han-Hsuan, Kuo, Wan-Ting, Wu, Shan-Ying, Lan, Sheng-Hui, Chang, Kai-Hsun, Lin, Pin-Lun, Lee, Ming-Fen, Cheng, Hung-Chi, Liu, Hsiao-Sheng, Huang, Chi-Ying F., Huang, Guan-Cheng, Su, Chun-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650649/
https://www.ncbi.nlm.nih.gov/pubmed/33036162
http://dx.doi.org/10.3390/cancers12102869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650649/
https://www.ncbi.nlm.nih.gov/pubmed/33036162
http://dx.doi.org/10.3390/cancers12102869

Ejemplares similares